Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
A high-level overview of CRISPR Therapeutics AG (CRSP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a ...
picks analysis by sector energy communication services real estate consumer staples tech basic materials healthcare consumer utilities financials industrials stock comparison tools faang stocks gold etfs cash equivalents big bank stocks big pharma stocks retail stocks top indexes dow jones s&p 500 nasdaq g...
That Chinese company that used or software is now listed on the HK stock exchange and worth a few hundred billion US dollars. Expand Where do you cut and paste your comments from? Just curious, because you sound like a completely brainwashed person incapable of your own...
(2 µL of a 50 ng/µL stock) in a 0.1 cm electroporation cuvette (Bio-Rad #1652089). The cuvette was placed in the electroporator (Bio-Rad #411BR) and pulsed at 1.8 kV for a duration of 5 ms. In total, 1.975 mL recovery media was added to each cuvette and...
Currently, the analyst consensus on Crispr Therapeutics AG is a Moderate Buy with an average price target of $64.00, a 29.7% upside from current levels. In a report released today, Barclays also maintained a Hold rating on the stock with a $55.00 pr...
— USA TODAY Tech (@usatodaytech)July 30, 2017 The hand of God is a familiar trope to describe advances in biotech. Elucidating CRISPR this way is sinful. If God were in the business of editing the genome, we expect that She would make fewer mistakes than CRISPR, which is known foroff...
Current Price $36.50 NYSE: BHC Bausch Health Companies Market Cap $3B Current Price $7.72 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. ...